WuXi PharmaTech Schedules Third Quarter 2008 Earnings Release on Wednesday, November...

* Reuters is not responsible for the content in this press release.

Thu Oct 23, 2008 6:05am EDT 

WuXi PharmaTech Schedules Third Quarter 2008 Earnings Release on Wednesday,
November 12, 2008
Earnings Conference Call to be Held on November 13, 2008 at 8:00 am (Eastern)
/ 5:00 am (Pacific) / 9:00 pm (Beijing/Hong Kong)

SHANGHAI, China, Oct. 23 /Xinhua-PRNewswire/ -- WuXi PharmaTech (Cayman)
Inc. (NYSE: WX), a leading pharmaceutical, biotechnology and medical device
R&D outsourcing company with operations in China and the United States, today
announced that it will release unaudited financial results for the third
quarter 2008 after the US market close on Wednesday, November 12, 2008.
    (Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO )
    The earnings release will be available on the investor relations section
of its website at http://www.wuxiapptec.com .
    Following the earnings announcement, WuXi PharmaTech senior management
will host a conference call at 8:00 am (Eastern) / 5:00 am (Pacific) / 9:00 pm
(Beijing/Hong Kong) on Thursday, November 13, 2008 to discuss its 2008 third
quarter financial results and recent business activities. The conference call
may be accessed by calling:
    Conference ID:           70474888
    United States            866-586-2813
    China, Northern Region   10-800-611-0127
    China, Southern Region   10-800-361-0079
    Hong Kong                800-965-808
    United Kingdom           0-800-056-9662
    International            +61-2-8524-6650

    A telephone replay will be available two hours after the call's completion
until December 14, 2008 at (US) +1-866-214-5335/ (HK) 800-901-596 / (China)
10-800-140-0386 / (UK) 0-800-731-7846 / (International) +61-2-8235-5000.
Passcode: 70474888.
    A live webcast of the conference call and replay will be available in the
investor relations section of WuXi PharmaTech's website at
http://www.wuxiapptec.com .
    About WuXi PharmaTech
    WuXi PharmaTech is a leading pharmaceutical, biotechnology and medical
device R&D outsourcing company, with operations in China and the United
States.
As a research-driven and customer-focused company, WuXi PharmaTech provides
pharmaceutical, biotechnology and medical device companies a broad and
integrated portfolio of laboratory and manufacturing services throughout the
drug and medical device R&D process. WuXi PharmaTech's services are designed
to assist its global partners in shortening the cycle and lowering the cost of
drug and medical device R&D. The operating subsidiaries of WuXi PharmaTech are
known as WuXi AppTec. For more information, please visit:
http://www.wuxiapptec.com .
    For further information, please contact:

    WuXi PharmaTech (Cayman) Inc.
     Dr. Hai Mi
     Executive Director of Investor Relations and Business Planning
     Tel:   +86-21-5046-3726
     Email: ir@wuxiapptec.com

    Burns McClellan
     Juliane Snowden
     Vice President of Investor Relations
     Tel:   +1-212-213-0006
     Email: jsnowden@burnsmc.com

SOURCE  WuXi PharmaTech (Cayman) Inc.

Dr. Hai Mi, Executive Director of Investor Relations and Business Planning,
WuXi PharmaTech (Cayman) Inc., +86-21-5046-3726, or ir@wuxiapptec.com;Or
Juliane Snowden, Vice President of Investor Relations, Burns McClellan,
+1-212-213-0006, or jsnowden@burnsmc.com
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.